Goobie Susan M, Haas Thorsten
aDepartment of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA bDepartment of Anesthesia, University Children's Hospital Zurich, Zurich, Switzerland.
Curr Opin Anaesthesiol. 2016 Jun;29(3):352-8. doi: 10.1097/ACO.0000000000000308.
Managing the bleeding pediatric patient perioperatively can be extremely challenging. The primary goals include avoiding hypotension, maintaining adequate tissue perfusion and oxygenation, and maintaining hemostasis. Traditional bleeding management has consisted of transfusion of autologous blood products, however, there is strong evidence that transfusion-related side-effects are associated with increased morbidity and mortality in children. Especially concerning is the increased reported incidence of noninfectious adverse events such as transfusion-related acute lung injury, transfusion-related circulatory overload and transfusion-related immunomodulation. The current approach in perioperative bleeding management of the pediatric patient should focus on the diagnosis and treatment of anemia and coagulopathy with the transfusion of blood products only when clinically indicated and guided by goal-directed strategies.
Current guidelines recommend that a comprehensive multimodal patient blood management strategy is critical in optimizing patient care, avoiding unnecessary transfusion of blood and blood product and limiting transfusion-related side-effects.
This article will highlight current guidelines in perioperative bleeding management for our most vulnerable pediatric patients with emphasis on individualized targeted intervention using point-of-care testing and specific coagulation products.
围手术期处理小儿出血患者极具挑战性。主要目标包括避免低血压、维持充足的组织灌注和氧合以及维持止血。传统的出血处理方法包括输注自体血制品,然而,有充分证据表明,输血相关的副作用与儿童发病率和死亡率增加有关。尤其值得关注的是,非感染性不良事件的报告发生率有所增加,如输血相关急性肺损伤、输血相关循环超负荷和输血相关免疫调节。小儿患者围手术期出血管理的当前方法应注重贫血和凝血功能障碍的诊断与治疗,仅在临床指征明确且以目标导向策略为指导时才输注血制品。
当前指南建议,全面的多模式患者血液管理策略对于优化患者护理、避免不必要的血液和血制品输血以及限制输血相关副作用至关重要。
本文将重点介绍针对我们最脆弱的小儿患者围手术期出血管理的当前指南,强调使用即时检验和特定凝血产品进行个体化靶向干预。